Stevanato Group S.p.A (STVN) Cash from Discontinued Operations (2020 - 2023)
Stevanato Group S.p.A's (STVN) quarterly Cash from Discontinued Operations came in at 40399094.94 in Q2 2023, down 10.28% year-on-year from 45029792.24 in Q2 2022, and down 10.28% on a QoQ basis from 45029792.24 in Q2 2022.
Stevanato Group S.p.A (STVN) Cash from Discontinued Operations (2020 - 2023) Analysis & Trends
Stevanato Group S.p.A (STVN) has 4 years of Cash from Discontinued Operations data on file, last reported at 40399094.94 in Q2 2023.
- On a quarterly basis, Cash from Discontinued Operations fell 10.28% year-over-year to 40399094.94 in Q2 2023; TTM through Jun 2023 was 169914120.95, a 12.72% decrease from a year earlier, with the FY2021 full-year figure at 157746845.05, down 15.03% from the prior year.
- Cash from Discontinued Operations for Q2 2023 stood at 40399094.94, down from 45029792.24 in the prior quarter.
- Over the last five years, Cash from Discontinued Operations for STVN reached as high as 72610451.82 in Q4 2020 and fell as low as 21109243.07 in Q3 2021.
- Historically, Cash from Discontinued Operations has averaged 53195628.51 across 4 years, with a median of 58944685.28 in 2020.
- On a YoY basis, Cash from Discontinued Operations climbed as much as 9.74% in 2021 and fell as far as 63.93% in 2021.
- Year by year, Cash from Discontinued Operations stood at 72610451.82 in 2020, then fell by 12.72% to 63375990.69 in 2021, then fell by 28.95% to 45029792.24 in 2022, then declined by 10.28% to 40399094.94 in 2023.
- Per Business Quant data, the three most recent Cash from Discontinued Operations figures were 40399094.94 in Q2 2023, 45029792.24 in Q2 2022, and 63375990.69 in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | - |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | - |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | - |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | - |
| 10 | Stevanato Group S.p.A | 5.29 Bn | 5.15 Bn | 88.01 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 40.40 Mn |
| Jun 30, 2023 | 40.40 Mn |
| Jun 30, 2022 | 45.03 Mn |
| Jun 30, 2022 | 45.03 Mn |
| Dec 31, 2021 | 63.38 Mn |
| Dec 31, 2021 | 63.38 Mn |
| Sep 30, 2021 | 21.11 Mn |
| Sep 30, 2021 | 21.11 Mn |
| Jun 30, 2021 | 65.15 Mn |
| Jun 30, 2021 | 65.15 Mn |
| Dec 31, 2020 | 72.61 Mn |
| Dec 31, 2020 | 72.61 Mn |
| Sep 30, 2020 | 58.52 Mn |
| Sep 30, 2020 | 58.52 Mn |
| Jun 30, 2020 | 59.37 Mn |
| Jun 30, 2020 | 59.37 Mn |